| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,193,000 | 5,719,000 | 5,089,000 | 5,509,000 | | Cost of Revenue | 3,171,000 | 2,977,000 | 2,772,000 | 3,101,000 | | | Gross Profit | 3,022,000 | 2,742,000 | 2,317,000 | 2,408,000 | | | Operating Expenses | | Research Development | 335,000 | 309,000 | 323,000 | 346,000 | | Selling General and Administrative | 1,209,000 | 1,242,000 | 1,191,000 | 1,307,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,478,000 | 1,191,000 | 803,000 | 755,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,000 | 7,000 | 11,000 | 29,000 | | Earnings Before Interest And Taxes | 1,486,000 | 1,198,000 | 814,000 | 784,000 | | Interest Expense | 55,000 | 55,000 | 55,000 | 57,000 | | Income Before Tax | 1,431,000 | 1,143,000 | 759,000 | 727,000 | | Income Tax Expense | 460,000 | 351,000 | 229,000 | 186,000 | | Minority Interest | (35,000) |
-
|
-
| (5,000) | | | | Net Income From Continuing Ops | 936,000 | 792,000 | 530,000 | 536,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 936,000 | 792,000 | 530,000 | 536,000 | | Preferred Stock And Other Adjustments | 21,000 | (9,000) | (12,000) |
-
| | | Net Income Applicable To Common Shares | $957,000 | $783,000 | $518,000 | $536,000 |
|
0.03% Nasdaq 
0.23 (0.27%) 
Income Statement
